Rationale: The clinical presentation and prognosis of non–cystic fibrosis bronchiectasis are
both very heterogeneous. Objectives: To identify different clinical phenotypes for non–cystic …

Rationale: Testing for underlying etiology is a key part of bronchiectasis management, but it
is unclear whether the same extent of testing is required across the spectrum of disease …

Introduction There is a relative lack of information about the death rate and morbidity of non-
cystic fibrosis bronchiectasis and most studies are limited due to referral bias. We wanted to …

Background: Data concerning phenotypes in bronchiectasis are scarce. Objective: The aim
of this study was to describe the clinical, functional and microbiological phenotypes of …

Background Few studies have evaluated the coexistence of bronchiectasis (BE) and chronic
obstructive pulmonary disease (COPD) in series of patients diagnosed primarily with BE …

There is renewed interest in non–cystic fibrosis bronchiectasis, which is a cause of
significant morbidity in adults and can be diagnosed by high-resolution chest computed …

This review article describes the epidemiology, clinical presentation, diagnostic workup and
treatment options in adult non-cystic fibrosis (non-CF) bronchiectasis (widening of mainly …

Bronchiectasis is a condition that has been increasingly diagnosed by chest HRCT. In the
literature, bronchiectasis is divided into bronchiectasis secondary to cystic fibrosis and …

Bronchiectasis is a heterogeneous and increasingly prevalent chronic pulmonary disease
that is associated with significant morbidity. In this review, we outline how patients with …

Update on non-cystic fibrosis bronchiectasis : Current Opinion in Pulmonary Medicine Update
on non-cystic fibrosis bronchiectasis : Current Opinion in Pulmonary Medicine Log in or …